Who
Peter Feinberg
Director
Company insider
Files Form 4 as: Director, Immuneering; Director, Notable Labs.
In numbers
- Trades disclosed
- 38
- Buys
- 12
- Sells
- 0
- Bought
- $5.3M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Aug 2021
- Last trade
- 11 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 11 Jun 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,350 at $0.00 | filing |
| 11 Jun 2026filed 11 Jun 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,350 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $87K20,000 at $4.35 | filing |
| 12 Jan 2026filed 14 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $87K20,000 at $4.35 | filing |
| 1 Jan 2026filed 2 Jan 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,888 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,888 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $50K7,500 at $6.67 | filing |
| 30 Sep 2025filed 1 Oct 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $53K7,500 at $7.03 | filing |
| 29 Sep 2025filed 30 Sep 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $36K5,000 at $7.18 | filing |
| 18 Jun 2025filed 23 Jun 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $63K25,000 at $2.53 | filing |
| 13 Jun 2025filed 16 Jun 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,350 at $0.00 | filing |
| 1 Jan 2025filed 2 Jan 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,485 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,350 at $0.00 | filing |
| 8 May 2024filed 10 May 2024 | Notable Labs | SEC FORM 4 Code A | —40,247 at $0.00 | filing |
| 22 Mar 2024filed 25 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $64K25,000 at $2.55 | filing |
| 19 Mar 2024filed 19 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $64K25,000 at $2.56 | filing |
| 18 Mar 2024filed 19 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $104K45,024 at $2.31 | filing |
| 18 Mar 2024filed 19 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $15K4,976 at $3.05 | filing |
| 24 Jan 2024filed 26 Jan 2024 | Notable Labsoption or derivative | SEC FORM 4 Code A | —9,753 at $0.00 | filing |
| 1 Jan 2024filed 2 Jan 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,879 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.